Identity
- Trade Name
- LIAISON® XL MUREX Control Anti-HBs FDA UDI
- Generic Name
- Hepatitis B virus surface total antibody IVD, control FDA UDI
- Model / Reference
- 318221 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 08056771103459 FDA UDI
- GMDN Term
- Hepatitis B virus surface total antibody IVD, control FDA UDI
Classification
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Hepatitis B virus surface total antibody IVD, control
LIAISON® XL MUREX Control Anti-HBs by Diasorin Inc. — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Hepatitis B virus surface total antibody IVD, control.
- VITROS — Ortho-Clinical Diagnostics · Class I
- Atellica™ IM aHBs2 QC — Siemens Healthcare Diagnostics · Class II
- ADVIA Centaur® Systems aHBs2 QC — Siemens Healthcare Diagnostics · Class II
- Alinity — Abbott Ireland Diagnostics · Class II
- PreciControl Anti-HBs — Roche Diagnostics Corp. · Class II
- ARCHITECT — Abbott Ireland Diagnostics · Class II
- ARCHITECT — Abbott Ireland Diagnostics · Class II
- ADVIA Centaur® Systems aHBs2 MCM — Siemens Healthcare Diagnostics · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | N/A | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Diasorin Inc.
Sources (1)
- FDA UDI 903cd607-30a8-4196-b659-add22d5819ba 32 fields · synced May 30, 2026